期刊文献+

含三唑的抗微生物药物研究进展 被引量:22

Advances in triazole antimicrobial agents
下载PDF
导出
摘要 含三唑的化合物是目前抗微生物药物研究开发中的热点领域之一。本文结合国内外文献简述了在抗菌、抗真菌、抗结核、抗病毒方面已经上市及正在进行临床试验的含三唑的药物,着重强调了含三唑的抗微生物药物及其构效关系的研发近况。随着研究的进一步发展,有望成功地开发出更多具有显著生物学活性的新药。 The advances of triazole compounds used as antimicrobial drugs are reviewed, including the research status of triazoles as antifungal, antibacterial, antituberculotic, antiviral agents and so on. As a significant pharmacophore, triazole nucleus appears diversified pharmacological activities in various types of antimicrobial agents and it is expected that new triazoles with potentially biological activity will be developed.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2007年第10期587-593,共7页 Chinese Journal of Antibiotics
基金 人事部回国人员重点项目(2002-99) 重庆市自然科学基金(2005BB5102)
关键词 三唑 抗菌 抗真菌 抗结核 抗病毒 Triazole Antibacterial Antifungal Antituberculotic Antiviral
  • 相关文献

参考文献4

二级参考文献30

  • 1侯芳,肖永红.新型抗真菌药物研究与临床应用[J].临床药物治疗杂志,2005,3(5):8-13. 被引量:6
  • 2Ng A W, Wasan K M, Lopez-Berestetin G. Development posomal polyene antibiotics: an historical perspective [J].J Pharm Sci,2003,6:67.
  • 3Hitchcock C A, Pye G W, Oliver G P, et al. UK-109,496; a novel, wide-spectrum triazol derivative for the treatment of fungal infection: antifungal activity and selectivity in vitro [C]. Washington D C. Microbiology Asf. 35th Intersciences conference on antimicrobial agents and chemotherapy, 1995.
  • 4Groll A H, Piscitelli S C, Walsh T J. Clinical pharmacology of systemic antifungal agents.. A comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development [J]. Adv Pharmacol, 1998,44:343.
  • 5Mora-Duarte J, Betts R, Rotstein C, et al, Comparison of caspofungin and amphotericin B for invasive candidiasis [J]. N Engl J Med,2002,347:2020.
  • 6Verduyn Lunel F M, Meis J F, Voss A. Nosocomial fungal infections: candidemia [J]. Diagn Microbiol Infect Dis,1999,34:213.
  • 7Kullberg B J, Oude Lashot A M. Epidemiology of opportunistic invasive mycoses [J]. Eur J Med Re.s, 2002,7: 183.
  • 8Ellis M. Invasive fungal infections: evolving challenges for diagnosis and therapeutics [J]. Mol Immunol, 2001,38:947.
  • 9Mckinsey D S. Making best use of the newer antifungal drugs [J]. Infect Meal,2003,20:392.
  • 10Carrillo-Munoz A J, Quindos G, Tur C, et al. In vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulfate, liposoreal amphotericin B, amphotericin B lipid complex,amphotericin B desoxycholate, fluconazole, and itraconazole [J]. J Antimicrob Chemother, 1999,44: 397.

共引文献47

同被引文献627

引证文献22

二级引证文献230

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部